Basit öğe kaydını göster

dc.contributor.authorSağ, Erdal
dc.contributor.authorGönç, Nazlı
dc.contributor.authorAlikaşifoğlu, Ayfer
dc.contributor.authorKuşkonmaz, Barış
dc.contributor.authorUçkan, Duygu
dc.contributor.authorÖzön, Alev
dc.contributor.authorKandemir, Nurgün
dc.date.accessioned2019-12-10T10:38:45Z
dc.date.available2019-12-10T10:38:45Z
dc.date.issued2015
dc.identifier.issn1308-5727
dc.identifier.urihttps://doi.org/10.4274/jcrpe.2295
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805214/
dc.identifier.urihttp://hdl.handle.net/11655/14077
dc.description.abstractHematopoietic stem cell transplantation (HSCT) is the only curative treatment for many hematological disorders, primary immunodeficiencies, and metabolic disorders. Thyroid dysfunction is one of the frequently seen complications of HSCT. However, hyperthyroidism due to Graves’ disease, autoimmune thyroiditis, and thyrotoxicosis are rare. Herein, we report a series of 4 patients who were euthyroid before HSCT but developed hyperthyroidism (3 of them developed autoimmune thyroid disease) after transplantation.
dc.relation.isversionof10.4274/jcrpe.2295
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleHyperthyroidism After Allogeneic Hematopoietic Stem Cell Transplantation: A Report Of Four Cases
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalJournal of Clinical Research in Pediatric Endocrinology
dc.contributor.departmentÇocuk Sağlığı ve Hastalıkları
dc.identifier.volume7
dc.identifier.issue4
dc.identifier.startpage349
dc.identifier.endpage354
dc.description.indexPubMed
dc.description.indexWoS
dc.description.indexScopus


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster